Literature DB >> 16267497

Global Measles and Rubella Laboratory Network, January 2004-June 2005.

.   

Abstract

Measles continues to be a leading cause of childhood morbidity and mortality in developing countries and an outbreak threat in the majority of countries. In 2000, measles was considered the fifth leading cause of childhood mortality, and the World Health Organization (WHO) estimated that approximately 777,000 measles-associated deaths occurred worldwide. In 2001, WHO and the United Nations Children's Fund (UNICEF) developed a 5-year strategic plan, endorsed by the World Health Assembly in 2003, to reduce measles mortality by 50% by 2005 (relative to 1999 estimates) and to achieve and maintain interruption of indigenous measles transmission in large geographic areas with established measles elimination goals. This plan included strengthening routine vaccination coverage, providing a second opportunity for measles immunization to children, improving measles case management, and improving surveillance with laboratory confirmation of suspected measles cases. To date, four of six WHO regions have established measles elimination targets: the Americas Region (AMR) by 2000, the European Region (EUR) by 2010, the Eastern Mediterranean Region (EMR) by 2010, and the Western Pacific Region (WPR) by 2012. The remaining two WHO regions, the African (AFR) and South East Asian (SEAR) regions, are continuing work toward the measles mortality reduction goal. Likewise, to reduce the burden of disease from congenital rubella syndrome (CRS), currently estimated at 100,000 cases per year worldwide, several countries have developed or continue to develop rubella control programs, and AMR and EUR have established regional rubella elimination and CRS reduction goals, respectively. Because improved global surveillance is essential for monitoring progress toward mortality reduction and elimination of these diseases, WHO established the Measles and Rubella Laboratory Network (LabNet) in 2003 to promote case identification and confirmation. This report provides an update on the development of LabNet during January 2004-June 2005 and describes the geographic distribution of measles and rubella virus genotypes as of June 2005.

Entities:  

Mesh:

Year:  2005        PMID: 16267497

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  17 in total

1.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

2.  Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem.

Authors:  C Stein-Zamir; G Zentner; N Abramson; H Shoob; Y Aboudy; L Shulman; E Mendelson
Journal:  Epidemiol Infect       Date:  2007-04-16       Impact factor: 2.451

3.  Measles laboratory-based surveillance in Zimbabwe during 2004-2009.

Authors:  Vurayai Ruhanya; Sylvester Rodgers Moyo
Journal:  Germs       Date:  2012-06-01

4.  Genetic characterization of wild-type measles viruses isolated in China, 2006-2007.

Authors:  Yixin Ji; Songtao Xu; Yan Zhang; Zhen Zhu; Naiying Mao; Xiaohong Jiang; Chao Ma; Peishan Lu; Changyin Wang; Yong Liang; Huanying Zheng; Yang Liu; Defang Dai; Lei Zheng; Jianhui Zhou; Shuang Wang; Zhenying Zhang; Shengwei Wu; Lijuan Nan; Li Li; Xiaofeng Liang; David Alexander Featherstone; Paul A Rota; William J Bellini; Wenbo Xu
Journal:  Virol J       Date:  2010-05-25       Impact factor: 4.099

5.  Phylogenetic analysis of rubella virus strains from an outbreak in Madrid, Spain, from 2004 to 2005.

Authors:  A O Martínez-Torres; M M Mosquera; J C Sanz; B Ramos; J E Echevarría
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

6.  Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid.

Authors:  Emily Abernathy; Cesar Cabezas; Hong Sun; Qi Zheng; Min-hsin Chen; Carlos Castillo-Solorzano; Ana Cecilia Ortiz; Fernando Osores; Lucia Oliveira; Alvaro Whittembury; Jon K Andrus; Rita F Helfand; Joseph Icenogle
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

7.  Genotypes of rubella virus and the epidemiology of rubella infections in the Democratic Republic of the Congo, 2004-2013.

Authors:  Elizabeth Pukuta; Diane Waku-Kouomou; Emily Abernathy; Benoit Kebela Illunga; Ricardo Obama; Vital Mondonge; Benjamin A Dahl; Balcha G Maresha; Joseph Icenogle; Jean-Jacques Muyembe
Journal:  J Med Virol       Date:  2016-04-05       Impact factor: 2.327

8.  Measles resurgence associated with continued circulation of genotype H1 viruses in China, 2005.

Authors:  Yixin Ji; Yan Zhang; Songtao Xu; Zhen Zhu; Shuyan Zuo; Xiaohong Jiang; Peishan Lu; Changyin Wang; Yong Liang; Huanying Zheng; Yang Liu; Naiying Mao; Xiaofeng Liang; David Alexander Featherstone; Paul A Rota; William J Bellini; Wenbo Xu
Journal:  Virol J       Date:  2009-09-08       Impact factor: 4.099

9.  Molecular evolution of measles viruses circulated in Taiwan 1992-2008.

Authors:  Wen-Yueh Cheng; Lili Lee; Paul A Rota; Dustin Chen-Fu Yang
Journal:  Virol J       Date:  2009-12-10       Impact factor: 4.099

10.  Molecular Epidemiology of Measles Virus before and after the 2003 Mass Vaccination Campaign for Measles/Rubella in Iran.

Authors:  M Naseri; V Salimi; T Mokhtari-Azad; A Esteghamati; Mm Gooya; Sa Nadji; Z Noroozbabaei; Sm Marashi; Z Saadatmand; F Rezaei; R Hamkar; H Triki
Journal:  Iran J Public Health       Date:  2011-03-31       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.